Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOPLEVEL: Teneligliptin and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus
jRCTs051180136Active, not recruiting
- Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of teneligliptin in type 2 diabetes mellitus (T2DM) and left ventricular diastolic dysfunction (LVDD) (4 cohorts), sponsored by Mitsubishi Tanabe Pharma Corporation. Primary endpoint: Change in E/e'. Started Jun 2015; status: active, not recruiting.
02
Drugs
teneligliptin
03
Conditions
type 2 diabetes mellitus (T2DM)left ventricular diastolic dysfunction (LVDD)
Beyond the preview
Go deeper on jRCTs051180136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051180136.